8-K current report · filed Nov 10, 2026

Prime Medicine, Inc. (PRME) 8-K Current Report: November 10, 2026

Item 2.02Item 8.01Item EX-99.1PRME overview

Short answer

Prime Medicine, Inc. (PRME) filed an 8-K current report with the SEC on November 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Preliminary liquidity of $61.2 million in cash, equivalents and short-term investments as of September 30, 2026.

Prime Medicine, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Preliminary liquidity of $61.2 million in cash, equivalents and short-term investments as of September 30, 2026
  • Restricted cash adds approximately $13.7 million, but is unavailable for general operating use
  • Cash estimate signals limited funding capacity for ongoing operations and clinical development
  • Unaudited figures remain subject to quarter-end adjustments and potential material changes
  • Complete third-quarter results expected in the Form 10-Q for the quarter ended September 30, 2026

Item 8.01 · Other Events

  • Updated corporate presentation posted November 10, 2026, providing investors with the company’s latest strategy and program materials
  • Exhibit 99.1 contains the substantive presentation, requiring review for pipeline, clinical, financial, and corporate updates

Item EX-99.1 · Exhibit EX-99.1

  • Prime Medicine targets Phase 1/2 initial data for PM577a Wilson disease and PM647 AATD programs in 2027
  • PM359 CGD program advancing toward BLA submission in the first half of 2027, pending final FDA alignment
  • PM577a focuses on H1069Q Wilson disease mutation, with follow-on programs potentially addressing R778L and other mutations
  • PM647 targets PiZZ AATD, with potential to restore healthy AAT protein levels through a one-time treatment
  • BMS collaboration provides $110 million upfront, more than $3.5 billion potential milestones and royalties on net sales

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Prime Medicine, Inc. 8-K filings

Get the next PRME 8-K as it lands

Follow PRME for push alerts, or ask the research agent what this filing means.